Watch QDEL. Know when insiders buy.
One email the day a filing lands. Free.
QDEL
QuidelOrtho Corp
10.94
+0.25 +2.34%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
65
PASS · shorts 65
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $750.2MP/E —DIV YIELD —FCF YIELD -28.15%REV TTM $2.7B −2.5%NET INCOME −$1BNET DEBT $2.6B52W 9.96 – 35.38SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2027 · Jun 28 | $630.9M | +2.8% | — | −$21.8M | −$92.9M | — | -1.36 | −$110.6M | $25.5M | −$136.1M | Aug 7 |
| Q1 2027 · Mar 29 | $619.8M | −10.5% | — | −$31.8M | −$91.8M | — | -1.35 | −$33M | $34M | −$67M | Aug 7 |
| Q4 2026 · Dec 28derived | $723.6M | +2.2% | — | −$66.3M | −$130.7M | — | -1.90 | $131.9M | $45.3M | $86.6M | Feb 19 |
| Q3 2026 · Sep 28 | $699.9M | −3.7% | — | −$704.8M | −$733M | — | -10.78 | −$45.5M | $49.2M | −$94.7M | Nov 6 |
| Q2 2026 · Jun 29 | $613.9M | −3.6% | — | −$180.7M | −$255.4M | — | -3.77 | −$46.8M | $37.5M | −$84.3M | Aug 7 |
| Q1 2026 · Mar 30 | $692.8M | −2.6% | — | $32.6M | −$12.7M | — | -0.19 | $65.6M | $56.2M | $9.4M | Aug 7 |
| Q4 2025 · Dec 29derived | $707.8M | −4.7% | — | −$100.4M | −$178.4M | −2648.6% | -2.62 | $63.7M | $47.2M | $16.5M | Feb 19 |
| Q3 2025 · Sep 29 | $727.1M | −2.3% | — | $15M | −$19.9M | — | -0.30 | $117.9M | $46.5M | $71.4M | Nov 6 |
| Q2 2025 · Jun 30 | $637M | — | — | −$117.5M | −$147.7M | — | -2.20 | −$97.9M | $35.3M | −$133.2M | Nov 6 |
| Q1 2025 · Mar 31 | $711M | — | — | −$1.8B | −$1.7B | — | -25.50 | −$700K | $66.1M | −$66.8M | Nov 6 |
| Q4 2024 · Dec 31derived | $742.6M | — | — | $40.1M | $7M | — | 0.11 | $80.4M | $48.6M | $31.8M | Feb 19 |
| Q3 2024 · Oct 1 | $744M | — | — | $26.3M | −$12.7M | — | -0.19 | $41.5M | $43.4M | −$1.9M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Dec 28 | $2.7B | — | −$919.2M | −$1.1B | -41.5% | -16.69 | $105.2M | $188.2M | −$83M | $0 | — |
| FY2025 · to Dec 29 | $2.8B | — | −$2B | −$2.1B | -73.7% | -30.54 | $83M | $195.1M | −$112.1M | $0 | — |
| FY2024 · to Dec 31 | $3B | — | $139.1M | −$10.1M | -0.3% | -0.15 | $280.2M | $209.3M | $70.9M | $7.2M | — |
| FY2023 · to Jan 1 | $3.3B | — | $843.7M | $548.7M | 16.8% | 9.56 | $885.3M | $140.9M | $744.4M | $74.3M | — |
| FY2022 · to Jan 2 | $1.7B | — | $906M | $704.2M | 41.5% | 16.43 | $805.9M | $292.8M | $513.1M | $103.5M | — |
| FY2021 · to Jan 3 | $1.7B | — | $1.1B | $810.3M | 48.8% | 18.60 | $629.7M | $64.9M | $564.8M | $43.7M | — |
Every number comes from QuidelOrtho Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.